Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis

Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis

In the diagnosis and prognosis of prostate cancer (PCa), the serum prostate-specific antigen test is widely used but is associated with low specificity. Therefore, blood-, urinary- and tissue-based biomarker tests have been developed, intended to be used in the diagnostic and prognostic setting of P...

Full description

Bibliographic Details
Main Authors: Wieke C. H. Visser, Hans de Jong, Willem J. G. Melchers, Peter F. A. Mulders, Jack A. Schalken
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
prostate cancer
cancer biomarkers
liquid biopsies
sPSA
Online Access:https://www.mdpi.com/2072-6694/12/12/3790

Internet

https://www.mdpi.com/2072-6694/12/12/3790

Similar Items